HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lurdes Matas Selected Research

sulfolipid I

1/2004Comparison of antibody responses to a potential combination of specific glycolipids and proteins for test sensitivity improvement in tuberculosis serodiagnosis.
10/2002Serodiagnosis of tuberculosis: comparison of immunoglobulin A (IgA) response to sulfolipid I with IgG and IgM responses to 2,3-diacyltrehalose, 2,3,6-triacyltrehalose, and cord factor antigens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lurdes Matas Research Topics

Disease

5Infections
04/2022 - 04/2015
3Pneumonia (Pneumonitis)
01/2021 - 10/2002
2Hepatitis C
12/2019 - 04/2014
2Tuberculosis (Tuberculoses)
01/2004 - 10/2002
1Human Influenza (Influenza)
01/2021
1Reinfection
01/2021
1Mycoplasma Pneumonia
10/2020
1Inflammation (Inflammations)
01/2018
1Glomerulonephritis
04/2016
1Erythema Infectiosum (Fifth Disease)
04/2016
1Syphilis
04/2015
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2012
1HIV Infections (HIV Infection)
08/2011
1Neoplasms (Cancer)
10/2010
1Lymphoma (Lymphomas)
10/2010
1Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2009
1Atypical Squamous Cells of the Cervix
07/2009
1Streptococcal Infections (Streptococcal Infection)
11/2008
1Rheumatic Fever (Acute Articular Rheumatism)
11/2008
1Pharyngitis (Sore Throat)
11/2008

Drug/Important Bio-Agent (IBA)

3Immunoglobulin M (IgM)IBA
01/2018 - 10/2002
2MacrolidesIBA
04/2022 - 10/2020
2Anti-Bacterial Agents (Antibiotics)IBA
10/2020 - 11/2008
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
04/2016 - 07/2009
2Immunoglobulin G (IgG)IBA
04/2016 - 10/2002
2EnzymesIBA
04/2015 - 08/2011
2Cord FactorsIBA
01/2004 - 10/2002
2sulfolipid IIBA
01/2004 - 10/2002
2Proteins (Proteins, Gene)FDA Link
01/2004 - 10/2002
2AntigensIBA
01/2004 - 10/2002
1FluoroquinolonesIBA
04/2022
1Pharmaceutical PreparationsIBA
01/2021
1Cocaine (Cocaine HCl)IBA
01/2021
1VaccinesIBA
01/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2021
1RNA (Ribonucleic Acid)IBA
12/2019
1Antiviral Agents (Antivirals)IBA
12/2019
1Ritonavir (Norvir)FDA Link
01/2018
1Darunavir (Prezista)FDA Link
01/2018
1Raltegravir PotassiumFDA Link
01/2018
1LopinavirFDA Link
01/2018
1AntibodiesIBA
04/2015
1Guanidine (Guanidine Nitrate)FDA Link
04/2015
1ParaffinIBA
05/2012
1Formaldehyde (Formol)FDA Link
05/2012
1Messenger RNA (mRNA)IBA
10/2010
1lipoarabinomannan (LAM)IBA
01/2004
1GlycolipidsIBA
01/2004
1Immunoglobulin A (IgA)IBA
10/2002

Therapy/Procedure

2Therapeutics
04/2014 - 11/2008
1Critical Care (Surgical Intensive Care)
01/2021
1Highly Active Antiretroviral Therapy (HAART)
04/2015